Table 1. Baseline characteristics of study subjects.
HBV-resolved(n = 425) | AsC(n = 240) | CHB(n = 217) | LC(n = 137) | |
Male | 191(44.90%) | 147(61.25%) | 148(68.20%) | 109(79.56%) |
Female | 234(55.06%) | 93(38.75%) | 69(31.80%) | 28(20.44%) |
age | 41.08±14.38 | 36.23±11.98 | 40.65±13.13 | 49.69±11.63 |
HBsAg+ | 0 | 240(100.0%) | 217(100.0%) | 137(100%) |
Anti-HBs+ | 410(96.47%) | 0 | 0 | 0 |
HBeAg+ | 0 | 56(23.33%) | 98(45.16%) | 21(15.33%) |
Anti-HBc+ | 398(93.65%) | 138(57.50%) | 142(65.44%) | 107(78.10%) |
ALT>40(IU/L) | 0 | 0 | 201(92.63%) | 46(33.58%) |